CPIG
ASND icon

Chicago Partners Investment Group’s Ascendis Pharma A/S ASND Stock Holding History

Chicago Partners Investment Group’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$572K Sell
2,264
-790
-26% -$185K 0.01% 915
2026
Q1 		$706K Sell
3,054
-444
-13% -$99.5K 0.02% 691
2025
Q4 		$823K Buy
3,498
+436
+14% +$90K 0.02% 526
2025
Q3 		$630K Sell
3,062
-670
-18% -$125K 0.02% 576
2025
Q2 		$635K Buy
3,732
+161
+5% +$26.2K 0.02% 507
2025
Q1 		$575K Sell
3,571
-1,654
-32% -$236K 0.02% 482
2024
Q4 		$702K Sell
5,225
-850
-14% -$112K 0.02% 421
2024
Q3 		$776K Sell
6,075
-151
-2% -$20.4K 0.03% 382
2024
Q2 		$834K Sell
6,226
-433
-7% -$58.9K 0.03% 358
2024
Q1 		$964K Sell
6,659
-227
-3% -$32.4K 0.04% 322
2023
Q4 		$924K Sell
6,886
-1,964
-22% -$196K 0.04% 314
2023
Q3 		$771K Buy
8,850
+1,562
+21% +$146K 0.04% 320
2023
Q2 		$665K Sell
7,288
-389
-5% -$33.9K 0.03% 355
2023
Q1 		$612K Buy
7,677
+5
+0.1% +$572 0.04% 340
2022
Q4 		$893K Sell
7,672
-2,287
-23% -$266K 0.05% 280
2022
Q3 		$1.24M Buy
9,959
+2,093
+27% +$198K 0.09% 207
2022
Q2 		$673K Buy
7,866
+85
+1% +$8.01K 0.05% 287
2022
Q1 		$669K Sell
7,781
-1,465
-16% -$170K 0.05% 260
2021
Q4 		$1.13M Buy
9,246
+185
+2% +$27.5K 0.08% 204
2021
Q3 		$1.4M Sell
9,061
-212
-2% -$29K 0.1% 176
2021
Q2 		$1.04M Sell
9,273
-1,868
-17% -$249K 0.08% 204
2021
Q1 		$1.51M Buy
11,141
+3,302
+42% +$502K 0.12% 143
2020
Q4 		$1.26M Buy
7,839
+4,537
+137% +$750K 0.12% 146
2020
Q3 		$550K Buy
+3,302
New +$475K 0.07% 217

Other funds holding ASND

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Chicago Partners Investment Group's ASND Position: Q2 2026 in Review

Chicago Partners Investment Group reduced its Ascendis Pharma A/S (ASND) stake by 26% in Q2 2026, selling an estimated $185K and leaving 2,264 shares worth $572K. The position accounts for 0.01% of the portfolio, ranked #915.

Chicago Partners Investment Group first reported a position in ASND in Q3 2020 and has held it in 24 quarters since. The position peaked at $1.51M in Q1 2021. 311 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

  • Chicago Partners Investment Group held 2,264 shares of Ascendis Pharma A/S worth $572K as of Q2 2026.
  • Chicago Partners Investment Group sold 790 Ascendis Pharma A/S shares in Q2 2026, an estimated $185K.
  • Ascendis Pharma A/S made up 0.01% of Chicago Partners Investment Group's portfolio in Q2 2026, its #915 holding.
  • Chicago Partners Investment Group first reported a position in Ascendis Pharma A/S in Q3 2020 and has held it in 24 quarters since.
  • Chicago Partners Investment Group's Ascendis Pharma A/S position peaked at $1.51M in Q1 2021.
  • 311 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on Chicago Partners Investment Group's 13F filing for Q2 2026, filed 30 Jul 2026.